hydralazine has been researched along with Injury, Myocardial Reperfusion in 6 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Excerpt | Relevance | Reference |
---|---|---|
" Moreover, A779 treatment attenuated the reduction in MAP and proteinuria by either captopril (300 mg/L in drinking water) or hydralazine (1." | 3.77 | Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester. ( Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH, 2011) |
"Pre-treatment with hydralazine was shown to inhibit both mitochondrial fission and mitochondrial membrane depolarisation induced by oxidative stress in HeLa cells." | 1.72 | Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission. ( Chinda, K; Costa, JRSD; Crespo-Avilan, GE; Hausenloy, DJ; Hernandez-Resendiz, S; Holien, JK; Kalkhoran, SB; Ketteler, R; Kriston-Vizi, J; Lees, JG; Lim, SY; Ling, NXY; Riquelme, JA; Rosdah, AA; Samangouei, P; Yap, EP; Yellon, DM, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, C | 1 |
Su, Z | 1 |
Ge, L | 1 |
Chen, Y | 1 |
Chen, X | 1 |
Li, Y | 1 |
Kalkhoran, SB | 1 |
Kriston-Vizi, J | 1 |
Hernandez-Resendiz, S | 1 |
Crespo-Avilan, GE | 1 |
Rosdah, AA | 1 |
Lees, JG | 1 |
Costa, JRSD | 1 |
Ling, NXY | 1 |
Holien, JK | 1 |
Samangouei, P | 1 |
Chinda, K | 1 |
Yap, EP | 1 |
Riquelme, JA | 1 |
Ketteler, R | 1 |
Yellon, DM | 1 |
Lim, SY | 1 |
Hausenloy, DJ | 1 |
Shinmura, K | 1 |
Tamaki, K | 1 |
Ito, K | 1 |
Yan, X | 1 |
Yamamoto, T | 1 |
Katsumata, Y | 1 |
Matsuhashi, T | 1 |
Sano, M | 1 |
Fukuda, K | 1 |
Suematsu, M | 1 |
Ishii, I | 1 |
Yang, W | 1 |
Li, H | 1 |
Luo, H | 1 |
Luo, W | 1 |
Benter, IF | 1 |
Yousif, MH | 1 |
Al-Saleh, FM | 1 |
Raghupathy, R | 1 |
Chappell, MC | 1 |
Diz, DI | 1 |
Przyklenk, K | 1 |
Kloner, RA | 1 |
6 other studies available for hydralazine and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Cardioprotection of hydralazine against myocardial ischemia/reperfusion injury in rats.
Topics: Animals; Cardiotonic Agents; Cell Line; Creatine Kinase, MB Form; Cytokines; Hydralazine; L-Lactate | 2020 |
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission.
Topics: Animals; Antioxidants; Apoptosis; Disease Models, Animal; Dynamins; Enzyme Inhibitors; Female; HeLa | 2022 |
Indispensable role of endothelial nitric oxide synthase in caloric restriction-induced cardioprotection against ischemia-reperfusion injury.
Topics: Animals; Caloric Restriction; Hydralazine; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; | 2015 |
Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.
Topics: Amine Oxidase (Copper-Containing); Animals; Blood Pressure; Chromatography, High Pressure Liquid; Di | 2011 |
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brai | 2011 |
Is "stunned myocardium" a protective mechanism? Effect of acute recruitment and acute beta-blockade on recovery of contractile function and high-energy phosphate stores at 1 day post-reperfusion.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Animals; Dogs; Echocardiography; Female; Hydral | 1989 |